Due to the combined efforts of the organization/universities to successfully deploy it, the enterprise-wide type would hold a significant market dominance. The University of Minnesota has had prior success with the implementation of enterprise-wide software. Oncology, cardiology, and paediatric medical research were areas that the university sought to support. The central purpose of CTMS was to support multi-dimensional studies, cancer trials, and pharmaceutical research. Leading pharmaceutical companies use enterprise-wide types like IMPACT CTMS as an example.
CROs would be claiming a sizable Clinical Trial Management System Market share as the end-user. The CROs' use of CTMS would be significantly impacted by the growing trend of outsourcing clinical trial studies to CROs. The life sciences sector is actively involved in the outsourcing of significant clinical work to CROs, expanding the CROs' market share, and utilising CTMS on their end.
Read More:
https://knackersblogger.blogspot.com/2022/12/clinical-trial-management-system-market.html
